A quick update on our favorite sector and the favorite stocks within the sector before we go to the weekend. Previously in this space multiple times we have provided price targets on the Semiconductor sector ETF 
SMH and the individual stocks like $NVDA. 
AVGO and $ASML. We have reiterated our targets for SMH and the stocks multiple times. In fact, SMH is above my long term target which is bullish.
NVDA rolling over. SMH looks vulnerable for NASDAQ:NVDA by RabishankarBiswal — TradingView
AVGO above its previous ATH and holding on. 400 $ reachable. for NASDAQ:AVGO by RabishankarBiswal — TradingView
ASML: Is the stock primed for upside? Indicators are aligned. for EURONEXT:ASML by RabishankarBiswal — TradingView
We stick to our targets from the posts above.NVDA to 250 $. AVGO to 400 $ and ASML to 980 $ - 1000 $. New target SMH to 360 $ to 3.618 Fib level.
Verdict: Semis have a good momentum. Stay long and strong.SMH to 360 $ before year end.
SMH and the individual stocks like $NVDA. AVGO and $ASML. We have reiterated our targets for SMH and the stocks multiple times. In fact, SMH is above my long term target which is bullish.NVDA rolling over. SMH looks vulnerable for NASDAQ:NVDA by RabishankarBiswal — TradingViewAVGO above its previous ATH and holding on. 400 $ reachable. for NASDAQ:AVGO by RabishankarBiswal — TradingViewASML: Is the stock primed for upside? Indicators are aligned. for EURONEXT:ASML by RabishankarBiswal — TradingViewWe stick to our targets from the posts above.
NVDA to 250 $. AVGO to 400 $ and ASML to 980 $ - 1000 $. New target SMH to 360 $ to 3.618 Fib level. Verdict: Semis have a good momentum. Stay long and strong.
SMH to 360 $ before year end. 
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.